ISSN 2618-4095 |
|
Scope and policy
The journal AJRPT publishes original articles as well as methodological works, which include translations and validations, and case reports. If you wish to obtain more information, access the "information for authors" section. The Argentinian Journal of Respiratory & Physical Therapy (AJRPT) accepts research studies in the field of respiratory and physical therapy, including clinical trials —basic or applied—, on the evaluation, prevention, and treatment of respiratory and motor disorders. Our Editorial Board is committed to disseminating high quality research articles in the field of respiratory and physical therapy. Roles and responsibilities of authors and contributors Who is an author? The International Committee of Medical Journal Editors (ICMJE) has developed four criteria for authorship to reduce ambiguity regarding the definition of the roles of authors and contributors. The criteria are as follows:
In addition to being partially responsible for the study, an author must be able to identify that their co-authors are also authors. Authors should have confidence in the integrity of their co-authors' contributions. Any person designated as an author must meet all four criteria that define authorship, and those who meet the criteria should be identified as authors. Individuals who do not meet the criteria should be acknowledged in the acknowledgments section. These criteria aim to reserve authorship status for those who deserve to be credited as authors and assume responsibility for the study. The individuals conducting the study are responsible for identifying who meets these criteria, ideally during the planning phase, making appropriate modifications as the study progresses. It is the collective responsibility of the authors, not the journal to which the study is submitted, to determine that all individuals listed as authors meet the four criteria. If a request is made to add or remove an author after the manuscript has been submitted or published, the journal's editors will request an explanation and require all authors mentioned, including the one to be removed or added, to sign a statement in accordance with the requested change. For any additional guidance on this matter, it is important to note that AJRPT follows the guidelines provided by COPE. The contributions made by each author in the research process should be systematically identified using the CRediT taxonomy (Contributor Roles Taxonomy). On the title page of the manuscript (download the title page template here), authorship roles should be identified in the following order, with each author assigned to their respective role and omitting roles that are not applicable to their research: Conceptualization: xxxxxx Each role is defined as follows: Additionally, on the main page, any editorial contribution made by external organizations, individuals, funding bodies, or individuals employed by funding sources should also be acknowledged. The corresponding author is the person who assumes responsibility for communication with the journal's editorial office during manuscript submission, peer review, and the editorial process. They are generally responsible for ensuring that all administrative requirements with the journal and details regarding authorship, ethical committee approval, clinical trial registration, and declaration of conflicts of interest are completed correctly, although these functions may be delegated to one or more co-authors. Throughout the submission and peer review process, the corresponding author should be available to respond to queries in a timely manner and, after publication, to address criticisms of the study and cooperate with anycorrections or retractions if necessary. Non-author contributors Contributors who do not meet the criteria for authorship but have made significant contributions to the research or the manuscript should be acknowledged in the acknowledgments section. This may include individuals who provided technical assistance, guidance, or valuable discussions but did not meet the criteria for authorship. Examples of activities that, by themselves (without other contributions), do not qualify a contributor as an author include: funding acquisition, general supervision of a research group, administrative support, assistance during writing, technical editing, translation, or proofreading. These contributions can be specified (for example, as scientific advisors, critical reviewers of the study proposal, data collection, providing participants, or attending to patients included in the study, participating in the writing or technical editing of the article). Unclear authorship criteria become evident in various circumstances and at different stages of the evaluation process and can lead to the suspension of the review process or even rejection of the article. Among the main problems identified, the following can be listed:
Plagiarism detection According to the policy of the journal, manuscripts must be original (drafted by the individuals who are listed as authors) and unpublished (not previously published in printed or digital format). To ensure academic integrity and prevent plagiarism, the journal implements a set of strategies to avoid plagiarism in publications as recommended by the COPE guidelines. Authors are required to refrain from committing plagiarism, which is defined as the appropriation of texts from other authors without their consent and without properly citing the source, even in cases where explicit permission has been obtained from the original authors. Additionally, authors are expected to avoid the inclusion of substantial parts of their own previously published works in the submitted texts, ensuring that there is no more than a 20% overlap between a previous text and the proposed work. The plagiarism check process is carried out during peer review. The journal's editors use an anti-plagiarism software tool (iThenticate) to analyze each article. If similarities exceeding 20% are detected, the article undergoes a thorough evaluation. The report generated by iThenticate is reviewed by the editors, who contact the authors to inform them about the percentage of plagiarism if it is deemed unacceptable. After this control process, the editors send a report to the author, which may result in the definitive rejection of the article or, alternatively, provide an opportunity to rewrite the work, properly citing the sources of the identified plagiarized texts. Please refer to the steps proposed by COPE in case a possible plagiarism is detected during the review process in the following link. PEER-REVIEW PROCESS The evaluation process is carried out under the protection of confidentiality, for which both the reviewers and the authors are unaware of their respective identities (double blind). Based on the opinions issued by external reviewers, the articles may be accepted for publication, rejected, or their publication is subject to compliance by the authors with the modifications requested by the reviewers. In case modifications are requested, authors must rework their papers and submit them within the indicated deadline to be re-evaluated. Each evaluation will have two double-blind evaluations. In case of controversy between the opinions, the editorial committee will resolve the decision based on the arguments given by the evaluators and the possibility of resorting to a third evaluation. Those articles that do not comply with the editorial guidelines of the journal will not be accepted for evaluation. CONDUCT AND BEST PRACTICES AJRPT adheres to the code of conduct and best practices established by the Committee on Publication Ethics (COPE) to ensure the quality of the articles published and properly address the needs of both readers and authors. |
Form and preparation of manuscripts
To publish in AJRPT, a submission must include the following files: - Cover Letter: Authors are required to send a cover letter describing how their study contributes to the field of respiratory and physical therapy and highlighting its clinical and/or scientific value. For guidelines, please click on Cover Letter. - Conflict of Interest: Authors are required to submit a conflict-of-interest disclosure. To download the conflict-of-interest disclosure form, please click here. - Title page: For guidelines, please click here. - Manuscript: To download a manuscript template, please click on original article, case report, or systematic review. - Figure/s: The combined number of figures and tables must not exceed 5 (for example, 3 tables and 2 figures). Surplus figures and tables may be included as "Supplementary Material". Click here to see guidelines for figures. - Supplementary material (if applicable). Supplementary material (for example, informed consent, ethics committee approval, figures, tables, protocols) may be included in a single word document. AJRPT highly recommends that health researchers use reporting guidelines while writing their manuscripts. The most commonly used reporting guidelines are available at the EQUATOR network website [www.equator-network.org]. Authors are required to follow the reporting guidelines for their specific study design and ensure that their manuscript addresses the reporting criteria. Complying with these basic requirements may greatly improve the value of their manuscript, facilitate/improve the peer-review process, and enhance their publication chances in AJRPT. For guidelines, click here. Read before proceeding: The combined number of figures and tables must not exceed 5 (for example, 3 tables and 2 figures). Surplus figures and/or tables may be included as "Supplementary Material". Figures must be attached in separate files in JPG, PNG or TIFF. Manuscripts must be submitted as a Microsoft Word file (.doc or .docx). Manuscripts must follow this order: title, abstract, quick look, main body, references, figure legends, figure contents, and tables. Manuscripts must include line numbers. The content of the manuscript must agree with the content of the metadata. The text of the manuscript must not exceed 4000 words (excluding abstract, keywords, references, figure/s, table/s, and quick look). Download template here. Title The full title must be in Spanish and English and agree with the title page. Abstract The abstract must not exceed 250 words. It must summarize the major aspects of the entire study. Findings not appearing in the main body should not be included in the abstract. If applicable, the abstract should include the ClinicalTrials.gov registration number. Submit 2 versions: in Spanish and English. The abstract must be structured according to the following sections:
Click here to see a tutorial video on identifying keywords. Quick Look The Quick Look section in AJRPT provides readers with a concise message of the study. Include the Quick Look section under the heading Quick Look at the beginning of your manuscript, between the title and the abstract. Current knowledge Write 2-4 declarative sentences summarizing current understanding of the topic being studied. Think of it as defining the state of the art. - State the current evidence on the subject, by providing clear declarative statements. What this study contributes to our knowledge Example of Quick Look Current knowledge The positive pressure OTE technique without endotracheal suction, compared with the traditional technique, showed no higher incidence of complications. Therefore, it could be performed in intensive care units. Main body The main body must not exceed 4000 words and must include the following 5 sections: Introduction. Specify what has been studied and why. It must include a theoretical framework, literature review, grounds, and objective. Materials and method. Describe how the study has been conducted. This section should provide enough details to allow the reader to judge the study's validity and replicate it. Indicate design, environment, duration, population, ethics and research committee approval, ClinicalTrial.gov registration number (if applicable), eligibility criteria, sampling method, variable operationalization, assessment procedures, data collection method, interventions, and statistical analysis. For statistical analysis and reporting guidelines, click here. Results. Report the findings of your study. This section includes the outcome of the study, without bias or interpretation or elements belonging to other sections. It is the shortest but most important section. Use past tense (passive voice is preferred). Report results from the general (e.g., sample characteristics) to the specific (e.g., primary and secondary outcomes). Be neutral, without bias or interpretation. Avoid redundancy, i.e., do not present the same data in a table and the text. Discussion. Interpret your study findings. In this section, include your study findings, interpretation of findings and their connection with the literature, limitations and strengths, suggestions for further research, and possible implications. Conclusion. This section provides a clear and concise answer to the primary objective of your study. References Authors are responsible for the accuracy of references. For example, “as reported in the literature.1,2,5,7 ” In the case of 3 or more correlative reference numbers, write the first and last, separated with a dash. For example, “ as reported in the literature. 1-6 ” Reference list must be numbered consecutively in the order they are first mentioned in the text. References cited only in tables or figure legends should be numbered following the order established by the first identification in the text of the table or figure. References must conform to the International Committee of Medical Journal Editors´ (ICMJE) recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals.
Include up to six authors. If more than six authors are included, list the first six and “et al”, except if there is a total of 7 authors. In that case, list all 7. Titles must be abbreviated in accordance with the List of Journals Indexed in Index Medicus, provided by the National Library of Medicine, available at www.ncbi.nlm.nih.gov/nlmcatalog/journals. Some examples are provided below. For further examples, visit https://www.nlm.nih.gov/bsd/uniform_requirements.html. Printed articles Dellinger RP, Vincent JL, Silva E, Townsend S, Bion J, Levy MM. Surviving sepsis in developing countries. Crit Care Med. 2008; 36 (8): 2487-8. Levy MM, Vincent JL, Jaeschke R, Parker MM, Rivers E, Beale R, et al. Surviving Sepsis Campaign: Guideline Clarification. Crit Care Med. 2008; 36 (8): 2490-1. Digital articles Buerke M, Prondzinsky R. Levosimendan in cardiogenic shock: better than enoximone! Crit Care Med [Internet]. 2008 [cited 2008 Aug 23]; 36 (8): 2450-1. Available from: http://www.ccmjournal.com/en/re/ccm/abstract.00003246-200808000-00038.htm Hecksher CA, Lacerda HR, Maciel MA. Características e evolução dos pacientes tratados com drotrecogina alfa e outras intervenções da campanha "Sobrevivendo à Sepse" na prática clínica. Rev Bras Ter Intensiva [Internet]. 2008[citado 2008 Ago 23; 20(2): 135- 43. Available at: http://www.scielo.br/pdf/rbti/v20n2/04.pdf Cochrane database articles Mayfield S, Jauncey-Cooke J, Hough JL, Schibler A, Gibbons K, Bogossian F. High-flow nasal cannula therapy for respiratory support in children. Cochrane Database Syst Rev. 2014. 7; 3: CD009850. Supplementary material Walker LK. Use of extracorporeal membrane oxygenation for preoperative stabilization of congenital diaphragmatic hernia. Crit Care Med. 1993; 21 (Supp. 1): S379-S380. Letters Haynes JM. Expiratory reserve volume maneuver may be the preferred method for some patients during spirometry testing (letter). Respir Care 2013; 58 (2): e14-e15. author response: e15. Books Doyle AC. Biological mysteries solved. 2nd ed. London: Science Press; 1991. Book chapters Lachmann B, van Daal GJ. Adult respiratory distress syndrome: animal models. In: Robertson B, van Golde LM. Pulmonary surfactant. 2nd ed. Amsterdam: Elsevier; 1992. p. 635-66. Published abstracts Varvinski AM, Findlay GP. Immediate complications of central venous cannulation in ICU [abstract]. Crit Care. 2000; 4 (Suppl 1): P6. Articles in the press Giannini A. Visiting policies and family presence in ICU: a matter for legislation? Intensive Care Med. In press 2012. Figure legends Although each figure is submitted as a separate file, figure legends must be embedded in the text of the manuscript. Every figure must include a legend explaining every component of the figure and any abbreviations. The legend should be self-sufficient and allow the reader to understand the figure without referring to the text. For example, Legends are placed at the end of the manuscript, after reference list. Figure content In order to facilitate edition, it is important to include in this section all the textual content of each figure. For example, Content of Figure 1: - 253 ICU/IMCU/ER Subjects Figure content must be at the end of the manuscript after Figure Legend. Table/s Each table must be embedded in the text of the manuscript in an editable format (not as an image) . Abbreviations Units of measurement. Use the decimal system, in which commas are used for decimal numbers (e.g.: 2,05). Use spaces, not commas, to separate thousands (e.g.: 1 000 000), except in thousand units < 10 000 (e.g. 9875). Abbreviations, initials, acronyms, and symbols. Avoid their use in title and abstract. Only standard units of measurement may be abbreviated without need to be defined. Abbreviations in the abstract or main body must be preceded by the complete term, unless it is an international standard measurement unit. For example: cmH2O, ml, kg, etc. Abbreviate only if a terms appears more than 5 times in the main body of the manuscript.
To start the submission process, you must be registered. If you are a first-time user, click here to register. Copyright Notice Authors who publish in this journal accept the following conditions: - Authors retain all moral and economic rights to their works, assigning only the right of first publication to AJRPT. Consequently, the authors may make other independent and additional contractual agreements for the distribution of the article or text. - Authors will retain their copyright and accept AJRPT's distribution license, which is Creative Commons Attribution - Share Alike License. - Authors may make other independent and additional contractual arrangements for the distribution of the version of the article published in this journal (e.g., inclusion in an institutional repository or publication in a book) as long as they clearly indicate that the work was first published in this journal. - Authors are allowed and encouraged to publish their work on the Internet (e.g., on institutional or personal pages) only once they are published in AJRPT, as it may lead to productive exchanges and faster and wider dissemination.
|
Sending of manuscripts
Before initiating the submission of your article, you need to have a username and password to access the platform. If you don't have these credentials, register by clicking [here]. If you already have a username and password, log in to the system [here]. After logging in, you will be directed to the "Submissions" screen. Click on "New submission" located on the right side of the screen to start the process of uploading your article. You will be guided through a five-step process. For detailed guidance on these steps, refer to the "Step-by-Step Guide". Before starting the submission, it is recommended to review the section "How to Prepare Your Article" to ensure the correct presentation of your work. |
[Home] [About the journal] [Editorial Board] [Subscription]
2024 ASOCIACIÓN CIVIL CIENTÍFICA DE DIFUSIÓN Y PROMOCIÓN DE LA KINESIOLOGÍA
Sanabria 4708
BOB1419, Buenos Aires
Argentina
Te. (54 11) 6878-8298
https://revista.ajrpt.com
info@ajrpt.com
SciELO Argentina URL: http://www.scielo.org.ar/scielo.php?script=sci_serial&pid=2618-4095&lng=es&nrm=iso